49 results
8-K
EX-99.1
ADPT
Adaptive Biotechnologies Corp
5 Apr 24
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
4:30pm
of completing its customary quarter-end close and review procedures as of and for the quarter ended March 31, 2024, and there can be no assurance
8-K
EX-10.1
sd6nrbwkpvssx1 03w
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am